# Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol

> **NCT03044652** · PHASE4 · COMPLETED · sponsor: **Dr. August Wolff GmbH & Co. KG Arzneimittel** · enrollment: 172 (actual)

## Conditions studied

- Vulvovaginal Atrophy

## Interventions

- **DEVICE:** WO2085 Moisturising Cream
- **DRUG:** Estriol Cream 0.1%

## Key facts

- **NCT ID:** NCT03044652
- **Lead sponsor:** Dr. August Wolff GmbH & Co. KG Arzneimittel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2017-07-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03044652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03044652, "Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03044652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*